SCHEMBL7112147

SCHEMBL7112147

N#Cc1cccc(-c2noc(C(F)F)c2-c2ccc(S(=O)(=O)O)c(F)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
PDE4A P27815 2/20 0.34
PDE4C Q08493 2/20 0.34
PDE4D Q08499 2/20 0.34
MAOB P27338 1/20 0.34
NR3C2 P08235 1/20 0.34
ACLY P53396 1/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
ESRRB O95718 1/20 0.33
ESRRA P11474 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
ATR Q13535 1/20 0.33
LRRK2 Q5S007 1/20 0.33
GRM5 P41594 1/20 0.32
NR1H4 Q96RI1 1/20 0.32
ADAMTS4 O75173 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6723268 0.90 PTGES2 (0.37) GABRG2GABRB3GABRA5GABRA3PDE4A
SCHEMBL6720061 0.90 NR3C2 (0.36) GABRG2GABRB3GABRA5GABRA3PDE4A
SCHEMBL7115446 0.83 BRD4 (0.40) MAOB
SCHEMBL6733934 0.82 CA1 (0.41) GABRG2GABRB3GABRA5GABRA3PDE4A
SCHEMBL6736967 0.82 NR1H4 (0.37) GABRG2GABRB3GABRA5GABRA3PDE4A
SCHEMBL7110955 0.81 MAPK14 (0.36)
SCHEMBL7108397 0.80 MAPK14 (0.38) ALDH1A1
SCHEMBL6725604 0.80 PTGS2 (0.37)
SCHEMBL6721402 0.80 PTGS2 (0.40) MAOB
SCHEMBL6739863 0.80 PTGES2 (0.37) GABRG2GABRB3GABRA5GABRA3PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296971-A2 2-FLUOROBENZENESULFONYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2003-04-02 EP disclosed
WO-2001081332-A2 2-FLUOROBENZENESULFONYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2001-11-01 WO disclosed